ArriVent BioPharma, Inc. (AVBP) stock
AVBPNasdaqPharmaceutical PreparationsFiscal year ends December 31
$10.69−0.87 (-7.53%)
Close on Nov 17, 2026Market cap $527.10MP/E –Yield –
ArriVent BioPharma price to book ratio
The price-to-book ratio is market cap divided by shareholders' equity.
ArriVent BioPharma's price to book ratio was 1.8× on Nov 11, 2026, against 3.1× a year earlier. Over the last 3 years it ranged from 1.8× to 4.9×, with a median of 3.1×.
Price to Book Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Nov 11, 2026 | 1.8× | −0.9 |
| 2025 | Dec 31, 2025 | 2.7× | −0.5 |
| 2024 | Dec 31, 2024 | 3.2× | – |
See a number that looks wrong?